Covid-19 Information for Health Professionals

 

 

The NCCP have developed a number of guidance documents that are available below and in the HSE COVID-19 Clinical Guidance and Evidence Repository 

 

Patient information on COVID-19

Patient information on COVID-19

Link

NCCP Covid-19 Advice for People with Cancer Link

 

Individual tumour site

Individual tumour site

Link 

Prostate

NCCP guidance for Medical Professionals on the management of patients with Prostate Cancer in response to the current novel coronavirus (COVID-19) outbreak

Link

Skin

NCCP advice for Medical Professionals on the Management of patients with Suspected or Diagnosed Malignant Melanoma or Non-Melanoma Skin Cancer in response to the current novel coronavirus (COVID-19) pandemic

Link
Psycho-oncology

Psycho-oncology

Link

Advice to inform safe re-opening of Cancer Support Centres                                                                                                                   Link
Radiation Oncology

Radiation Oncology

Link

NCCP patient pathway for attendance for radiation oncology during the COVID-19 pandemic Link
NCCP advice on the management of patients undergoing radiation oncology treatment, in response to the current novel coronavirus (COVID-19) outbreak Link
NCCP advice on radiation therapy capacity escalation plan in response to the current COVID 19 pandemic Link
NCCP guidance on the use of PPE by medical professionals when managing patients requiring radiotherapy in response to the current novel coronavirus (COVID-19) outbreak Link
NCCP advice for medical professionals on acceptable dose fractionation during the novel coronavirus (COVID-19) pandemic Link
Guidance on the Management of Treatment Gaps and Interruptions in Radical Fractionated Radiotherapy Arising from the COVID 19 Pandemic Link
Breast cancer: NCCP guidance for Medical Professionals on the management of patients undergoing Breast Cancer Radiotherapy in response to the current novel coronavirus (COVID-19) outbreak Link
Prostate cancer: NCCP advice for Medical Professionals on the management of patients undergoing Prostate Cancer Radiotherapy in response to the current novel coronavirus (COVID-19) outbreak Link
Thyroid cancer: NCCP advice for medical professionals on the management of Thyroid Cancer and Overactive Thyroid Disease in response to the current novel coronavirus (COVID-19) pandemic Link
Head and Neck cancers: NCCP guidance for Medical Professionals on the management of patients with head and neck cancer undergoing radiotherapy in response to the current COVID-19 pandemic Link
CNS cancer: NCCP advice for medical professionals on the treatment of patients with CNS tumours with radiotherapy in response to the COVID-19 pandemic Link
Lung cancer: NCCP advice for medical professionals on the management of patients undergoing Lung Cancer Radiotherapy in response to the current novel coronavirus (COVID-19) pandemic Link
Rapid Access Clinics

Rapid Access Clinics

Link

NCCP Communication to GPs on Rapid Access Cancer Clinics in light of the current Covid-19 pandemic

Link

Breast

NCCP advice for Medical Professionals on the management of patients referred to the Symptomatic Breast Clinic in response to the current novel coronavirus (COVID-19) pandemic

Link

NCCP advice for Medical Professionals on minimising COVID19 risk in the Symptomatic Breast Disease Clinics 

Link

COVID-19 Capacity Response Plan for Symptomatic Breast Disease (SBD) Clinics

Link

Prostate

NCCP guidance for Medical Professionals on the management of patients referred to the Rapid Access Prostate Clinics in response to the current novel coronavirus (COVID-19) pandemic

Link

Lung

NCCP advice for Medical Professionals on the management of patients referred to the Rapid Access Lung Clinics in response to the current novel coronavirus (COVID-19) pandemic

Link
Surgery

Surgery

Link

NCCP patient pathway for admission for cancer surgery during the COVID-19 pandemic Link
NCCP advice for medical professionals on surgical oncology during the COVID-19 pandemic                                                                    Link
NCCP guidance for Medical Professionals for testing COVID19 in asymptomatic patients undergoing elective cancer surgery in response to the current novel coronavirus pandemic Link
Rapid review of literature on a perioperative COVID-19 infection in cancer patients undergoing surgery Link
Systemic Anti-Cancer Therapy

Systemic Anti-Cancer Therapy

Link

NCCP advice for Medical Professionals on the management of patients undergoing Systemic Anti-Cancer Therapy (chemotherapy) in response to the current coronavirus (COVID-19) outbreak

Link

 

Testing

Testing

Link

COVID-19 testing may be requested for asymptomatic patients prior to certain scheduled treatments.  It is not a ‘rule-out’ test and will be used alongside advice to patients on reducing their likelihood of exposure in the two weeks prior to attendance and clinical review for signs and symptoms of disease. The below document outlines the process of requesting a test.  This includes an option of having the swab taken by the National Ambulance Service, in which case the laboratory testing is still carried out by your usual hospital.  
NCCP guidance for Medical Professionals for testing COVID19 in asymptomatic patients undergoing elective cancer surgery in response to the current novel coronavirus pandemic Link
NCCP patient pathway for admission for cancer surgery during the COVID-19 pandemic Link
NCCP patient pathway for attendance for SACT on an haematology/oncology day ward during the COVID-19 pandemic Link
NCCP patient pathway for admission to an haematology/oncology ward during the COVID-19 pandemic Link

Updated: 10/02/2022